Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Complement C4d anticorps (CF®568)

C4d Reactivité: Humain IF, ELISA, Coat Hôte: Souris Monoclonal TDM16 CF®568
N° du produit ABIN6173894
  • Antigène Tous les produits Complement C4d (C4d)
    Complement C4d (C4d) (Complement Component C4d (C4d))
    Reactivité
    • 32
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 25
    • 7
    Souris
    Clonalité
    • 26
    • 6
    Monoclonal
    Conjugué
    • 15
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Cet anticorp Complement C4d est conjugé à/à la CF®568
    Application
    • 21
    • 20
    • 16
    • 10
    • 8
    • 8
    • 6
    • 5
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Immunofluorescence (IF), ELISA, Coating (Coat)
    Fonction
    Mouse Monoclonal anti-Complement C4d (TDM16), CF568 Conjugate
    Attributs du produit
    This MAb is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound C4d.C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 Molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment. Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
    Immunogène
    Human Complement 4d protein
    Clone
    TDM16
    Isotype
    IgG1
  • Indications d'application
    Immunofluorescence 0.5-1.0 μg/mL
    • ELISA For coating use Ab at 1-2 μg/mL, order Ab without BSA
    • Optimal dilution for a specific application should be determined by user
    Commentaires

    Rejected Renal Transplant Tissue

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    100 μg/mL
    Buffer
    PBS/0.1 % BSA/0.05 % azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Protect from light
  • Antigène
    Complement C4d (C4d) (Complement Component C4d (C4d))
    Autre désignation
    Complement C4d (C4d Produits)
    Poids moléculaire
    192 kDa (predicted)
    ID gène
    720, 721
Vous êtes ici:
Support technique